Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas. This evidence concerns the gene BMI1 and head and neck squamous cell carcinoma.